Manufactured Object – Page 26

The Closure of Walmart Health Highlights Significant Hurdles for Retail Health Innovators

12 months ago talkbio0Tagged accessibility, competition, disruptors, Engaged to be married, Health, Health care facility, innovation, Landscapes, Reparative closure, Walmart Health

Walmart Health, retail health, disruptors, challenges, closure, innovation, healthcare, accessibility, competition, patient engagement, healthcare landscape.

Enlaza Secures $100M for Groundbreaking Irreversible Protein Binding Technology

12 months ago talkbio0Tagged Biotechnology, Drug Development, Enlaza, Investments, irreversible, Medical Research activity, Protein Binding

Enlaza, funding, investment, protein binding, irreversible, biotechnology, medical research, drug development, therapeutics.

Novartis Invests $180M in PeptiDream to Boost Radiopharmaceutical Development

12 months ago talkbio0Tagged Cancer Therapeutic Procedure, cellular targeting, Drug Development, Investments, Isotopes, Novartis, Partnership, PeptiDream, Radioactivity, Radiopharmaceuticals

Novartis, PeptiDream, radiopharmaceuticals, investment, drug development, partnership, targeted therapies, cancer treatment, radioactive isotopes.

FDA Approval Milestones: X4 Pharmaceuticals, Pfizer, and Genmab Secure Nods for Rare Disease and Cervical Cancer Treatments

12 months ago talkbio0Tagged Biotechnology, Drug Approval, Genmab, Health care facility, Malignant tumor of cervix, Pfizer, United States Food and Drug Administration

FDA, X4 Pharmaceuticals, Pfizer, Genmab, rare disease, cervical cancer, drug approval, treatment, healthcare, biotechnology.

Pfizer’s Revolutionary Hemophilia B Gene Therapy Gains FDA Approval and Introduces Unique Warranty Program

12 months ago talkbio0Tagged Approved, Biotechnology, Blood coagulation, gene therapy, Health care facility, Hemophilia B, Hereditary Diseases, Pfizer, United States Food and Drug Administration

Pfizer, FDA, Hemophilia B, Gene Therapy, Approval, Warranty, Treatment, Genetic Disorder, Blood Clotting, Healthcare, Biotechnology

Cigna’s Evernorth Pushes for Increased Humira Biosimilar Adoption

12 months ago talkbio0Tagged AbbVie, Biosimilars, Cigna, Evernorth, Financial cost, Financial savings, Health care facility, Humira, Pharmaceutical Services

Cigna, Evernorth, Humira, biosimilars, healthcare, pharmacy services, cost savings, patient access, AbbVie

FDA Approves Pfizer’s Hemophilia B Gene Therapy with a $3.5 Million Price Tag

12 months ago talkbio0Tagged Approved, Biotechnology, Financial cost, gene therapy, Health care facility, Hemophilia B, Hereditary Diseases, Pfizer, Pricing, United States Food and Drug Administration

Pfizer, FDA, hemophilia B, gene therapy, approval, pricing, healthcare, biotechnology, rare diseases, genetic disorders, treatment cost.

Regeneron Pharmaceuticals Expands Gene Editing Capabilities with Mammoth Biosciences Partnership

12 months ago talkbio0Tagged Biotechnology, Clustered Regularly Interspaced Short Palindromic Repeats, development aspects, Gene Modification, Genetic Research, Health care facility, Mammoth Biosciences, Partnership, Regeneron

Regeneron, Mammoth Biosciences, gene editing, CRISPR, partnership, biotechnology, healthcare, pharmaceuticals, genetic research, therapeutic development.